Innovative Affymetrix™ products that help advance the gene expression investigations of cancer researchers via microarray analysis, from discovery to clinical research and validation.
Cancer RNA Expression
Next-generation sequencing and advances in real-time PCR (qPCR) throughput have revolutionized the way differential gene expression is analyzed, including variability between gene alleles and differently spliced transcripts, non-coding RNAs, post-transcriptional mutations and editing, and gene fusions. Currently, DNA microarrays are the most widely used method to analyze global patterns of gene expression.
Discover, profile, and functionally analyze more mRNA and non-coding RNAs that regulate cancer with sequencing technologies that provide significant advantages over microarray and flexible real-time PCR assay formats for meeting high, medium, and low throughput needs.
Identify and quantify both known and novel transcripts with a theoretically unlimited dynamic range. Reveal the diversity and subtleties of the transcriptome with Ion RNA-Seq on Ion Proton™ Sequencer or the 5500xl SOLiD® Sequencer.
Determine relative changes in human RNA expression without the need to sequence the entire transcriptome with as little as 5ng of RNA isolated from formalin-fixed, paraffin-embedded (FFPE) samples.
Learn how Life Technologies solutions are being used to identify novel RNA expression signatures from across the human transcriptome and overcome many of the challenges of working with tumor tissues in the research setting.
|A specialized TaqMan® Array for pancreatic cancer research combining mRNA and miRNA analysis in a single microfluidic card|
Speakers: Timothy Triche, Audrey Papp, Rob Tarbox
Speaker: Dr. Malte Buchholz
Cancer RNA Expression Posters
Access scientific posters demonstrating new results and methodologies in cancer RNA expression profiling from recent scientific conferences.
For Research Use Only. Not for use in diagnostic procedures.